Ribonucleic Acid News and Research

RSS
Researchers introduce new method for observing cell interactions

Researchers introduce new method for observing cell interactions

New bioinformatics method for viral sgRNA analysis

New bioinformatics method for viral sgRNA analysis

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Role of interferon type I-driven responses associated with disease control in COVID-19

Role of interferon type I-driven responses associated with disease control in COVID-19

Novel nanopore technique for annotation of SARS-CoV-2 capping sites and understanding sgRNA structure

Novel nanopore technique for annotation of SARS-CoV-2 capping sites and understanding sgRNA structure

Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid antigen

Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid antigen

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Structure-guided virtual screening identifies novel SARS-CoV-2 Mpro inhibitors

Structure-guided virtual screening identifies novel SARS-CoV-2 Mpro inhibitors

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

Extended host range for SARS-CoV-2 variants of concern

Extended host range for SARS-CoV-2 variants of concern

Immunity found 6 months after SARS-CoV-2 infection in children

Immunity found 6 months after SARS-CoV-2 infection in children

Do we need COVID-19 vaccine boosters?

Do we need COVID-19 vaccine boosters?

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

The antimicrobial properties of the lungfish cocoon

The antimicrobial properties of the lungfish cocoon

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.